Maria F. Nani
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Microbiota and lipid mediators: from molecular crosstalk to therapeutic opportunities.
Journal: Frontiers in pharmacology
Published: March 23, 2026
Microbiome crosstalk and nutrition: the interplay between gut microbiota-organ axis and dietary factors.
Journal: Food research international (Ottawa, Ont.)
Published: December 19, 2025
Preclinical Studies on Plant Based-Antacid Formulations as New Therapies for Gastro-Oesophageal Reflux Disease.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 25, 2025
N-Acylethanolamines in cancer: mechanisms and therapeutic potential of lipid regulators of tumor behavior.
Journal: Progress in lipid research
Published: July 11, 2025
Correction: Understanding the role of the gut microbiome in gastrointestinal cancer: A review.
Journal: Frontiers in pharmacology
Published: July 09, 2025
Sex hormones influence ORMDL3 expression: Implications for sex-associated asthma phenotype.
Journal: The Journal of allergy and clinical immunology
Published: May 07, 2025
Dietary targeting of TRPM8 rewires macrophage immunometabolism reducing colitis severity.
Journal: Cell death & disease
Published: June 27, 2024
Polyphenol-Rich Extract from 'Limoncella' Apple Variety Ameliorates Dinitrobenzene Sulfonic Acid-Induced Colitis and Linked Liver Damage.
Journal: International journal of molecular sciences
Published: January 12, 2024
Pharmacological Inhibition of N-Acylethanolamine Acid Amidase (NAAA) Mitigates Intestinal Fibrosis Through Modulation of Macrophage Activity.
Journal: Journal of Crohn's & colitis
Published: December 21, 2023
Zosterabisphenone B, a new diarylheptanoid heterodimer from the seagrass Zostera marina, induces apoptosis cell death in colon cancer cells and reduces tumour growth in mice.
Journal: Phytotherapy research : PTR
Published: July 26, 2023
Understanding the role of the gut microbiome in gastrointestinal cancer: A review.
Journal: Frontiers in pharmacology
Published: December 23, 2022
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling.
Journal: British journal of pharmacology
Published: March 03, 2022
Last Updated: 09/26/2026